{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:39:01Z","timestamp":1784907541322,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Capital Fund for Health Improvement and Research","award":["2016-2-4021"],"award-info":[{"award-number":["2016-2-4021"]}]},{"name":"Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2016L04"],"award-info":[{"award-number":["LC2016L04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Information on the optimal salvage regimen for recurrent esophageal cancer is scarce. We aimed to assess the patterns of locoregional failure, and evaluate the therapeutic efficacy of salvage therapy along with the prognostic factors in recurrent thoracic esophageal squamous cell carcinoma (TESCC) after radical esophagectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 193 TESCC patients who were diagnosed with recurrence after radical surgery and received salvage treatment at our hospital were retrospectively reviewed from 2004 to 2014. The patterns of the first failure were assessed. The post-recurrence survival rate was determined using the Kaplan-Meier method and analyzed using the log-rank test. Multivariate prognostic analysis was performed using the Cox proportional hazard model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median time of failure was 7.0\u2009months. Among the 193 patients, 163 exhibited isolated locoregional lymph node (LN) recurrence and 30 experienced locoregional LN relapse with hematogenous metastasis. Among the 193 patients, LN recurrence was noted at 302 sites; the most common sites included the supraclavicular (25.8%; 78\/302) and mediastinal LNs (44.4%; 134\/302), particularly stations 1 to 6 for the mediastinal LNs (36.4%; 110\/302). The median overall survival (OS) was 13.1\u2009months after recurrence. In those treated with salvage chemoradiotherapy, with radiotherapy, and without radiotherapy, the 1-year OS rates were 68.5, 55.0, and 28.6%; the 3-year OS rates were 35.4, 23.8, and 2.9%; and the 5-year OS rates were 31.8, 17.2, 2.9%, respectively (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001). Furthermore, patient survival in those who received salvage chemoradiotherapy was significantly better than those treated with salvage radiotherapy alone (<jats:italic>P<\/jats:italic>\u00a0=\u20090.044). Multivariate analysis showed that the pathological TNM stage and salvage treatment regimen were independent prognostic factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Supraclavicular and mediastinal LN failure were the most common types of recurrence after R0 surgery in TESCC patients. Salvage chemoradiotherapy or radiotherapy could significantly improve survival in esophageal cancer with locoregional LN recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-6622-0","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T16:02:36Z","timestamp":1582387356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Wenjie","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-6814","authenticated-orcid":false,"given":"Zefen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jima","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"key":"6622_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s11605-011-1458-1","volume":"15","author":"PK Hsu","year":"2011","unstructured":"Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558\u201365.","journal-title":"J Gastrointest Surg"},{"key":"6622_CR2","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1245\/s10434-011-1747-7","volume":"18","author":"H Miyata","year":"2011","unstructured":"Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M, Doki Y. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18:3353\u201361.","journal-title":"Ann Surg Oncol"},{"key":"6622_CR3","first-page":"549","volume":"25","author":"J Lu","year":"2013","unstructured":"Lu J, Tao H, Song D, Chen C. Recurrence risk model for esophageal cancer after radical surgery. Chin J Cancer Res. 2013;25:549\u201355.","journal-title":"Chin J Cancer Res"},{"key":"6622_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","volume":"32","author":"V Oppedijk","year":"2014","unstructured":"Oppedijk V, van der Gaast A, van Lanschot JJB, van Hagen P, van Os R, van Rij CM, et al. Patterns of recurrence after surgery alone versus preoperative Chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32:385\u201391.","journal-title":"J Clin Oncol"},{"key":"6622_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097225","volume":"9","author":"Q Liu","year":"2014","unstructured":"Liu Q, Cai XW, Wu B, Zhu ZF, Chen HQ, Fu XL. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy. PLoS One. 2014;9:e97225.","journal-title":"PLoS One"},{"key":"6622_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13019-014-0150-4","volume":"9","author":"XF Guo","year":"2014","unstructured":"Guo XF, Mao T, Gu ZT, Ji CY, Fang WT, Chen WH. Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma. J Cardiothorac Surg. 2014;9:150.","journal-title":"J Cardiothorac Surg"},{"key":"6622_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jjco\/hyx171","volume":"48","author":"T Kawamoto","year":"2018","unstructured":"Kawamoto T, Nihei K, Sasai K, Karasawa K. Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancer. Jpn J Clin Oncol. 2018;48:259\u201364.","journal-title":"Jpn J Clin Oncol"},{"key":"6622_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009777","volume":"97","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Ding N, Wang L, Liu W, Jiang M, Lu J. Salvage radiochemotherapy for lymph node recurrence after radical surgery of esophageal cancer. Medicine. 2018;97:e9777.","journal-title":"Medicine"},{"key":"6622_CR9","doi-asserted-by":"crossref","unstructured":"Nemoto K, Ariga H, Kakuto Y, Matsushita H, Takeda K. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol. 2001;2:165-8.","DOI":"10.1016\/S0167-8140(01)00392-9"},{"key":"6622_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.radonc.2010.04.029","volume":"96","author":"W Cai","year":"2010","unstructured":"Cai W, Xin P. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy. Radiother Oncol. 2010;96:104\u20137.","journal-title":"Radiother Oncol"},{"key":"6622_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/1759-7714.12499","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Cai X, Liu Q, Li H, Cheng Y, Fu X. Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer. Thorac Cancer. 2017;8:630\u20133.","journal-title":"Thorac Cancer"},{"key":"6622_CR12","volume":"12","author":"J Chen","year":"2017","unstructured":"Chen J, Cai W, Lin Y, Chen Y, Zheng Q, Pan J, Chen C. Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma. PLoS One. 2017;12:e185424.","journal-title":"PLoS One"},{"key":"6622_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamasurg.2014.2877","volume":"150","author":"B Li","year":"2015","unstructured":"Li B, Xiang J, Zhang Y, Li H, Zhang J, Sun Y, et al. Comparison of Ivor-Lewis vs sweet Esophagectomy for esophageal squamous cell carcinoma. JAMA Surg. 2015;150:292.","journal-title":"JAMA Surg"},{"key":"6622_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/gut.37.2.174","volume":"37","author":"JL Raoul","year":"1995","unstructured":"Raoul JL, Le Prise E, Meunier B, Julienne V, Etienne PL, Gosselin M, Launois B. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut. 1995;37:174\u20136.","journal-title":"Gut"},{"key":"6622_CR15","first-page":"949","volume":"6","author":"X Su","year":"2014","unstructured":"Su X, Zhang D, Zhang X, Lin P, Long H, Rong T. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis. 2014;6:949\u201357.","journal-title":"J Thorac Dis"},{"key":"6622_CR16","unstructured":"Sang M, Chen J, Liu H. Result of treatment for recurrence of esophageal cancer after surgery. China Oncol. 2000;10:35\u20137."},{"key":"6622_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ijrobp.2009.08.065","volume":"78","author":"JC Lu","year":"2010","unstructured":"Lu JC, Kong C, Tao H. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;78:710\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6622_CR18","unstructured":"Li B, Zhang W, Zhao L, Liu N, Pang Q, Yuan Z, et al. Therapeutic strategies for recurrence of esophageal cancer after radical resection. Chin J Clin Oncol. 2013;40:1553\u20137."},{"key":"6622_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"SZ Lai","year":"2011","unstructured":"Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80:661\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6622_CR20","first-page":"2060","volume":"120","author":"DJ Sher","year":"2014","unstructured":"Sher DJ, Koshy M, Liptay MJ, Fidler MJ. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Cancer Am Cancer Soc. 2014;120:2060\u20138.","journal-title":"Cancer Am Cancer Soc"},{"key":"6622_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0360-3016(79)90044-0","volume":"5","author":"GG Steel","year":"1979","unstructured":"Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys. 1979;5:85\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6622_CR22","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","volume":"16","author":"M Al-Sarraf","year":"1998","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998;16:1310\u20137.","journal-title":"J Clin Oncol"},{"key":"6622_CR23","first-page":"1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JJ, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiat Ther Oncol Group JAMA. 1999;281:1623\u20137.","journal-title":"Radiat Ther Oncol Group JAMA"},{"key":"6622_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/jjco\/hym138","volume":"37","author":"Y Shioyama","year":"2007","unstructured":"Shioyama Y, Nakamura K, Ohga S, Nomoto S, Sasaki T, Yamaguchi T, et al. Radiation therapy for recurrent esophageal Cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol. 2007;37:918\u201323.","journal-title":"Jpn J Clin Oncol"},{"key":"6622_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1748-717X-7-93","volume":"7","author":"J Zhang","year":"2012","unstructured":"Zhang J, Peng F, Li N, Liu Y, Xu Y, Zhou L, et al. Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer. Radiat Oncol. 2012;7:93.","journal-title":"Radiat Oncol"},{"key":"6622_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/SLA.0000000000001767","volume":"264","author":"MC Anderegg","year":"2016","unstructured":"Anderegg MC, Lagarde SM, Jagadesham VP, Gisbertz SS, Immanuel A, Meijer SL, et al. Prognostic significance of the location of lymph node metastases in patients with adenocarcinoma of the distal esophagus or Gastroesophageal junction. Ann Surg. 2016;264:847\u201353.","journal-title":"Ann Surg"},{"key":"6622_CR27","doi-asserted-by":"crossref","unstructured":"Okamura A, Watanabe M, Kozuki R, Toihata T, Yuda M, Imamura Y, Mine S. Supraclavicular and celiac metastases in squamous cell carcinoma of the middle thoracic esophagus. Langenbeck's Arch Surg. 2018;403:977-84.","DOI":"10.1007\/s00423-018-1722-x"},{"key":"6622_CR28","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1245\/s10434-008-0016-x","volume":"15","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, Mitsuhashi N. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol. 2008;15:2451\u20137.","journal-title":"Ann Surg Oncol"},{"key":"6622_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/1471-2407-12-542","volume":"12","author":"K Jingu","year":"2012","unstructured":"Jingu K, Matsushita H, Takeda K, Umezawa R, Takahashi C, Sugawara T, et al. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study. BMC Cancer. 2012;12:542.","journal-title":"BMC Cancer"},{"key":"6622_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1748-717X-9-28","volume":"9","author":"DY Ma","year":"2014","unstructured":"Ma DY, Tan BX, Liu M, Li XF, Zhou YQ, Lu Y. Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study. Radiat Oncol. 2014;9:28.","journal-title":"Radiat Oncol"},{"key":"6622_CR31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00268-011-0978-x","volume":"35","author":"T Kosuga","year":"2011","unstructured":"Kosuga T, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, Otsuji E. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection. World J Surg. 2011;35:798\u2013804.","journal-title":"World J Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6622-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T02:30:28Z","timestamp":1613874628000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6622-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6622"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6622-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,22]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board approval was obtained for the retrospective study from the ethical committee of the Chinese Academy of Medical Sciences. Written informed consent is obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}